Hostname: page-component-848d4c4894-2xdlg Total loading time: 0 Render date: 2024-06-17T00:58:54.600Z Has data issue: false hasContentIssue false

Long–term Neurodevelopment outcomes to Prenatal Antipsychotic Medication Exposure: Systemic Review

Published online by Cambridge University Press:  19 July 2023

T. González Campos*
Affiliation:
Psychiatry, University Hospital “Dr.José E. González” Universidad Autónoma de Nuevo León, Monterrey, Mexico

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Peak incidence for many psychiatric disorders occurs in reproductive years. We don’t have FDA-approved drugs or clinical guidelines. The main cause of pharmacological suspension in pregnancy is the lack of knowledge of their effects on the product. Gathering information on this regard becomes crucial so we can avoid relapses or exacerbation

Objectives

Describe neurodevelopmental effects in children ≥ 6 months exposed to antipsychotics prenatally.

Methods

PROSPERO-CRD42020170314. Using MeSH terms in 5 databases, without language and time restriction, obtaining n=3932. After review and exclusion n=24 were obtained for qualitative review. (Figure 1).

Results

Of 20 case reports 4 had more ambivalence results (Table 1). In the cohort studies, exposure may cause short-term delay at 6 months but no significant difference at 12 months (Table 2).Table 2

StudyNAntipsychoticMonthsConclusion using clinical evaluation
Imaz et al. Front. Pharmacol.2018; 9:2641RisperdalClozapine72Abnormal memory, attention/executive, hyperactivity
1Clozapine32Normal
2Clozapine18Abnormal
Normal
Burt et al. Am J Psychiatry 2010; 167:892-8971Olanzapine12,18,22,2918 months Abnormal motor 22 months normal 29 months normal
Kirchheiner et al. Pharmacopsych 2000; 33:78-801Olanzapine7,117 months Abnormal motor11 months Normal
Mendhekar et al. J Neuropsychiatry Clin Neurosci 2007; 19:21Clozapine65 years Abnormal language
Table 3
StudyNAntipsychoticMonthsConclusion using clinimetry and clinical evaluation
Shao et al. Plos ONE, 2015; 10(4),1-963ClozapineRisperidoneOlanzapineQuetiapine6,12BSID-III 6 months Adaptive behavior score lower in clozapine group 12 months No difference
Johnson et al. Arch Gen Psychiatry2012; 69(8), 787-79422HaloperidolSGA*6INFANIB Lower scores with SGA then Haloperidol
Peng et al. Psychopharmacology 2013; 228(4), 577-58476ClozapineRisperidoneSulpirideOlanzapineQuetiapine6,12BSID-III 6 months Lower socio-emotional and adaptive behavior scores12 months No difference
Petersen et al. BMJ 2016; 5(6), 1-9290FGA+SGA**6More neurodevelopmental disorder that those who didn’t take antipsychotics.

Image:

Conclusions

Most are case reports, hence the importance of collecting this information, not ignoring it due to lack of methodological rigor. The intent is not to conclude that prenatal exposure to antipsychotics doesn’t have long-term neurodevelopmental effects, rather documenting the available evidence contributing to an informed clinical decision.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.